ResearcherUniversitätsmedizin GöttingenActive in the last 2 years
Lennart Versemann
Matched on ORCID iD 0000-0003-2104-8700; OpenAlex author ID A5002453771. Sources: OpenAlex.
Their work
- Papers
- 5
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 21
2020: 1 paper · 2021: 1 paper · 2022: 2 papers · 2023: none · 2024: 1 paper
Papers 5
- An NFATc1/SMAD3/cJUN Complex Restricted to SMAD4-Deficient Pancreatic Cancer Guides Rational Therapies. Co-author DOI 10.1053/j.gastro.2023.10.026↗
- Epigenetic Therapeutic Strategies to Target Molecular and Cellular Heterogeneity in Pancreatic Cancer. Co-author DOI 10.1159/000519859↗
- TP53-Status-Dependent Oncogenic EZH2 Activity in Pancreatic Cancer. Co-author DOI 10.3390/cancers14143451↗
- Chromatin-Independent Interplay of NFATc1 and EZH2 in Pancreatic Cancer. Co-author DOI 10.3390/cells10123463↗
- EZH2 Regulates Pancreatic Cancer Subtype Identity and Tumor Progression via Transcriptional Repression of GATA6. Co-author DOI 10.1158/0008-5472.can-20-0672↗
Closest collaborators
The 21 strongest of 21 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Elisabeth Heßmann · 5 shared papers, 2020–2024 · strength 0.74
- Paper Epigenetic Therapeutic Strategies to Target Molecular and Cellular Heterogeneity in Pancreatic Cancer. DOI 10.1159/000519859↗
- Paper TP53-Status-Dependent Oncogenic EZH2 Activity in Pancreatic Cancer. DOI 10.3390/cancers14143451↗
- Paper An NFATc1/SMAD3/cJUN Complex Restricted to SMAD4-Deficient Pancreatic Cancer Guides Rational Therapies. DOI 10.1053/j.gastro.2023.10.026↗
- Shiv K. Singh · 4 shared papers, 2020–2024 · strength 0.48
- Paper TP53-Status-Dependent Oncogenic EZH2 Activity in Pancreatic Cancer. DOI 10.3390/cancers14143451↗
- Paper An NFATc1/SMAD3/cJUN Complex Restricted to SMAD4-Deficient Pancreatic Cancer Guides Rational Therapies. DOI 10.1053/j.gastro.2023.10.026↗
- Paper Chromatin-Independent Interplay of NFATc1 and EZH2 in Pancreatic Cancer. DOI 10.3390/cells10123463↗
- Albrecht Neeße · 4 shared papers, 2020–2024 · strength 0.48
- Paper TP53-Status-Dependent Oncogenic EZH2 Activity in Pancreatic Cancer. DOI 10.3390/cancers14143451↗
- Paper An NFATc1/SMAD3/cJUN Complex Restricted to SMAD4-Deficient Pancreatic Cancer Guides Rational Therapies. DOI 10.1053/j.gastro.2023.10.026↗
- Paper Chromatin-Independent Interplay of NFATc1 and EZH2 in Pancreatic Cancer. DOI 10.3390/cells10123463↗
- Volker Ellenrieder · 4 shared papers, 2020–2024 · strength 0.48
- Paper TP53-Status-Dependent Oncogenic EZH2 Activity in Pancreatic Cancer. DOI 10.3390/cancers14143451↗
- Paper An NFATc1/SMAD3/cJUN Complex Restricted to SMAD4-Deficient Pancreatic Cancer Guides Rational Therapies. DOI 10.1053/j.gastro.2023.10.026↗
- Paper Chromatin-Independent Interplay of NFATc1 and EZH2 in Pancreatic Cancer. DOI 10.3390/cells10123463↗
- Maria Ulisse · 2 shared papers, 2022–2024 · strength 0.40
- Shilpa Patil · 3 shared papers, 2020–2022 · strength 0.34
- Paper TP53-Status-Dependent Oncogenic EZH2 Activity in Pancreatic Cancer. DOI 10.3390/cancers14143451↗
- Paper Chromatin-Independent Interplay of NFATc1 and EZH2 in Pancreatic Cancer. DOI 10.3390/cells10123463↗
- Paper EZH2 Regulates Pancreatic Cancer Subtype Identity and Tumor Progression via Transcriptional Repression of GATA6. DOI 10.1158/0008-5472.can-20-0672↗
- Steven A. Johnsen · 2 shared papers, 2020–2024 · strength 0.22
- Jochen Gaedcke · 2 shared papers, 2020–2021 · strength 0.20
- Marie C. Hasselluhn · 1 shared paper, 2024 · strength 0.13
- Ulrich Sax · 1 shared paper, 2024 · strength 0.13
- Maximilian Reichert · 1 shared paper, 2024 · strength 0.13
- Stephan A. Hahn · 1 shared paper, 2024 · strength 0.13
- Feda H. Hamdan · 1 shared paper, 2024 · strength 0.13
- Carolin Schneider · 1 shared paper, 2024 · strength 0.13
- Christoph Ammer‐Herrmenau · 1 shared paper, 2024 · strength 0.13
- Günter Schneider · 1 shared paper, 2024 · strength 0.13
- Alexander Otto König · 1 shared paper, 2024 · strength 0.13
- Kenneth P. Olive · 1 shared paper, 2024 · strength 0.13
- Xin Wang · 1 shared paper, 2020 · strength 0.08
- Jin‐San Zhang · 1 shared paper, 2020 · strength 0.08
- Laura Urbach · 1 shared paper, 2020 · strength 0.08
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.